Daniel J. Safer

8.1k total citations
122 papers, 6.2k citations indexed

About

Daniel J. Safer is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Daniel J. Safer has authored 122 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Psychiatry and Mental health, 57 papers in Clinical Psychology and 32 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Daniel J. Safer's work include Attention Deficit Hyperactivity Disorder (49 papers), Child and Adolescent Psychosocial and Emotional Development (45 papers) and Pharmaceutical studies and practices (24 papers). Daniel J. Safer is often cited by papers focused on Attention Deficit Hyperactivity Disorder (49 papers), Child and Adolescent Psychosocial and Emotional Development (45 papers) and Pharmaceutical studies and practices (24 papers). Daniel J. Safer collaborates with scholars based in United States, Germany and Netherlands. Daniel J. Safer's co-authors include Julie M. Zito, Richard P. Allen, Susan dosReis, James F. Gardner, Karen L. Soeken, Eric M. Fine, Laurence S. Magder, Mehmet Burcu, Mark A. Riddle and Frances L. Lynch and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Psychiatry.

In The Last Decade

Daniel J. Safer

117 papers receiving 5.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel J. Safer United States 44 3.7k 2.8k 1.3k 985 670 122 6.2k
Julie M. Zito United States 40 4.0k 1.1× 2.9k 1.1× 1.5k 1.2× 762 0.8× 373 0.6× 119 6.1k
Philip Hazell Australia 46 3.0k 0.8× 3.8k 1.4× 481 0.4× 1.3k 1.3× 365 0.5× 162 6.8k
Kapil Sayal United Kingdom 44 3.3k 0.9× 3.1k 1.1× 1.2k 0.9× 1.2k 1.3× 745 1.1× 169 6.5k
Regina Bussing United States 36 2.5k 0.7× 2.8k 1.0× 471 0.4× 1.1k 1.1× 732 1.1× 125 4.5k
Andrés Martin United States 44 3.0k 0.8× 2.6k 0.9× 533 0.4× 1.9k 1.9× 268 0.4× 179 6.1k
Mary A. Fristad United States 43 3.6k 1.0× 4.1k 1.5× 532 0.4× 565 0.6× 327 0.5× 201 6.3k
Mark L. Wolraich United States 38 4.7k 1.3× 2.4k 0.9× 961 0.8× 1.7k 1.7× 1.4k 2.1× 123 6.3k
Maurício Silva de Lima Brazil 29 4.1k 1.1× 1.7k 0.6× 500 0.4× 1.7k 1.7× 824 1.2× 73 6.2k
Joseph R. Holbrook United States 23 2.6k 0.7× 1.8k 0.6× 599 0.5× 1.1k 1.1× 659 1.0× 42 4.0k
Janet Wozniak United States 52 6.7k 1.8× 4.0k 1.4× 630 0.5× 2.0k 2.0× 292 0.4× 160 8.4k

Countries citing papers authored by Daniel J. Safer

Since Specialization
Citations

This map shows the geographic impact of Daniel J. Safer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Safer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Safer more than expected).

Fields of papers citing papers by Daniel J. Safer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Safer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Safer. The network helps show where Daniel J. Safer may publish in the future.

Co-authorship network of co-authors of Daniel J. Safer

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Safer. A scholar is included among the top collaborators of Daniel J. Safer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Safer. Daniel J. Safer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Safer, Daniel J.. (2023). Lorazepam use during clinical trials of adults with bipolar mania episodes. Contemporary Clinical Trials Communications. 33. 101122–101122. 1 indexed citations
2.
Yang, Bo Kyum, Mehmet Burcu, Daniel J. Safer, Alison M. Trinkoff, & Julie M. Zito. (2018). Comparing Nurse Practitioner and Physician Prescribing of Psychotropic Medications for Medicaid-Insured Youths. Journal of Child and Adolescent Psychopharmacology. 28(3). 166–172. 10 indexed citations
3.
Burcu, Mehmet, Julie M. Zito, Daniel J. Safer, et al.. (2017). Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus. Journal of the American Academy of Child & Adolescent Psychiatry. 56(8). 642–651. 34 indexed citations
4.
Burcu, Mehmet, et al.. (2014). Atypical Antipsychotic Use Among Medicaid-Insured Children and Adolescents: Duration, Safety, and Monitoring Implications. Journal of Child and Adolescent Psychopharmacology. 24(3). 112–119. 42 indexed citations
5.
Safer, Daniel J., et al.. (2013). Prolactin Serum Concentrations During Aripiprazole Treatment in Youth. Journal of Child and Adolescent Psychopharmacology. 23(4). 282–289. 27 indexed citations
6.
Safer, Daniel J., et al.. (2012). Age-grouped differences in bipolar mania. Comprehensive Psychiatry. 53(8). 1110–1117. 12 indexed citations
7.
Zito, Julie M., et al.. (2012). National Trends in Pediatric Use of Anticonvulsants. Psychiatric Services. 63(11). 1095–1101. 9 indexed citations
8.
Zito, Julie M., Albert Derivan, Christopher J. Kratochvil, et al.. (2008). Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring. Child and Adolescent Psychiatry and Mental Health. 2(1). 24–24. 83 indexed citations
9.
Zito, Julie M., Daniel J. Safer, Katrin Janhsen, et al.. (2008). A three-country comparison of psychotropic medication prevalence in youth. Child and Adolescent Psychiatry and Mental Health. 2(1). 26–26. 148 indexed citations
10.
Zito, Julie M., Daniel J. Safer, Satish Valluri, et al.. (2007). Psychotherapeutic Medication Prevalence in Medicaid-Insured Preschoolers. Journal of Child and Adolescent Psychopharmacology. 17(2). 195–204. 75 indexed citations
11.
Safer, Daniel J. & Julie M. Zito. (2006). Treatment-Emergent Adverse Events from Selective Serotonin Reuptake Inhibitors by Age Group: Children versus Adolescents. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 159–169. 129 indexed citations
12.
Zito, Julie M., Daniel J. Safer, James F. Gardner, Karen L. Soeken, & Jae Chun Ryu. (2006). Anticonvulsant Treatment for Psychiatric and Seizure Indications Among Youths. Psychiatric Services. 57(5). 681–685. 18 indexed citations
13.
Safer, Daniel J., Julie M. Zito, & Susan dosReis. (2003). Concomitant Psychotropic Medication for Youths. American Journal of Psychiatry. 160(3). 438–449. 139 indexed citations
14.
Safer, Daniel J., Julie M. Zito, & James F. Gardner. (2001). Pemoline Hepatotoxicity and Postmarketing Surveillance. Journal of the American Academy of Child & Adolescent Psychiatry. 40(6). 622–629. 47 indexed citations
15.
Zito, Julie M., Daniel J. Safer, Susan dosReis, et al.. (1999). Psychotherapeutic Medication Patterns for Youths With Attention-Deficit/Hyperactivity Disorder. Archives of Pediatrics and Adolescent Medicine. 153(12). 1257–1257. 137 indexed citations
16.
Zito, Julie M. & Daniel J. Safer. (1997). Sources of Data for Pharmacoepidemiological Studies of Child and Adolescent Psychiatric Disorders. Journal of Child and Adolescent Psychopharmacology. 7(4). 237–253. 14 indexed citations
17.
Safer, Daniel J.. (1997). Changing Patterns of Psychotropic Medications Prescribed by Child Psychiatrists in the 1990s. Journal of Child and Adolescent Psychopharmacology. 7(4). 267–274. 67 indexed citations
18.
Safer, Daniel J.. (1996). Attention deficit hyperactivity disorder: Pinning down the diagnosis, implementing therapy. 36(3). 533–545. 1 indexed citations
19.
Safer, Daniel J.. (1995). An outpatient/inpatient comparison of child psychiatric diagnosis.. American Journal of Orthopsychiatry. 65(2). 298–303. 7 indexed citations
20.
Safer, Daniel J. & Richard P. Allen. (1989). Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children. The Journal of Pediatrics. 115(6). 1003–1008. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie M. Zito Breakdown of academic impact, for papers by Philip Hazell Breakdown of academic impact, for papers by Kapil Sayal Breakdown of academic impact, for papers by Regina Bussing Breakdown of academic impact, for papers by Andrés Martin Breakdown of academic impact, for papers by Mary A. Fristad Breakdown of academic impact, for papers by Mark L. Wolraich Breakdown of academic impact, for papers by Maurício Silva de Lima Breakdown of academic impact, for papers by Joseph R. Holbrook Breakdown of academic impact, for papers by Janet Wozniak
Rankless by CCL
2026